These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Mattick RP; Breen C; Kimber J; Davoli M Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD002207. PubMed ID: 24500948 [TBL] [Abstract][Full Text] [Related]
10. Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders. Carney T; Van Hout MC; Norman I; Dada S; Siegfried N; Parry CD Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012254. PubMed ID: 32068247 [TBL] [Abstract][Full Text] [Related]
11. Opioid antagonists with minimal sedation for opioid withdrawal. Gowing L; Ali R; White JM Cochrane Database Syst Rev; 2017 May; 5(5):CD002021. PubMed ID: 28553701 [TBL] [Abstract][Full Text] [Related]
13. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Amato L; Minozzi S; Davoli M; Vecchi S Cochrane Database Syst Rev; 2011 Sep; (9):CD005031. PubMed ID: 21901695 [TBL] [Abstract][Full Text] [Related]
14. Alphaâ‚‚-adrenergic agonists for the management of opioid withdrawal. Gowing L; Farrell M; Ali R; White JM Cochrane Database Syst Rev; 2016 May; 2016(5):CD002024. PubMed ID: 27140827 [TBL] [Abstract][Full Text] [Related]
15. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Amato L; Minozzi S; Davoli M; Vecchi S; Ferri MM; Mayet S Cochrane Database Syst Rev; 2008 Oct; (4):CD005031. PubMed ID: 18843675 [TBL] [Abstract][Full Text] [Related]
16. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Amato L; Minozzi S; Davoli M; Vecchi S; Ferri MM; Mayet S Cochrane Database Syst Rev; 2008 Jul; (3):CD005031. PubMed ID: 18646118 [TBL] [Abstract][Full Text] [Related]
17. Buprenorphine for the management of opioid withdrawal. Gowing L; Ali R; White J Cochrane Database Syst Rev; 2006 Apr; (2):CD002025. PubMed ID: 16625553 [TBL] [Abstract][Full Text] [Related]
18. Buprenorphine for the management of opioid withdrawal. Gowing L; Ali R; White JM Cochrane Database Syst Rev; 2009 Jul; (3):CD002025. PubMed ID: 19588330 [TBL] [Abstract][Full Text] [Related]
19. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799 [TBL] [Abstract][Full Text] [Related]
20. Buprenorphine for the management of opioid withdrawal. Gowing L; Ali R; White J Cochrane Database Syst Rev; 2004 Oct; (4):CD002025. PubMed ID: 15495026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]